Hospital · Alken · BE · Founded 1989 · Accounts through 2025 · Updated Jul 29, 2026
Public range today€12k - €26k
Review the public valuation range based on filed annual accounts. Complete the data to improve accuracy, understand the range and identify concrete action points.
Is this your company? Claim and manage this profile
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accounts| Fiscal year | Low | High |
|---|---|---|
| 2024 | €70k | €160k |
| 2025 | €12k | €26k |
Complete the public data for a more precise valuation, the insights behind it, and concrete action points that can increase business value.
Free account · private workspace
Public filings are a starting point. Owner-confirmed accounts, net debt, leases and commercial context can refine the range for a sale, financing or transfer.
You have seen the public curve. Create a free account to complete the data, refine the valuation, and discover concrete action points.
A concise view of fiscal year 2025. The financial report owns the multi-period statements, ratios, definitions, and source history.
BE · FY 2025 · Reported · Source: cbso_bulk · Updated: Jul 29, 2026
Each report is a separate, sourced dataset with enough history to answer a distinct question.
Register your interest privately. Upswitch reviews every request and keeps it queued until a safe, verified owner contact route is available.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Claim this companyOperating as a hospital, INFARMED is registered in Alken, Belgium. The company was founded in 1989, incorporated as a Besloten Vennootschap.
INFARMED is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0437680232 and VAT number BE0437680232. This profile consolidates KBO registry, official annual accounts into one indexable company dossier.
Within the Belgian NACE 86.10 cluster, public-record data is filed annually via the national company registry.
Across the 2024-2025 window the gross-margin line has declined, moving from €29,559 to €6,983. EBITDA for 2025 comes in at €4,301. Because this line is gross margin from an abbreviated filing, not reported turnover, it is treated as public context rather than an automatic valuation base.
A public indicative value curve is available for INFARMED, based on filed company accounts. Complete the data to refine the valuation and identify concrete action points.
The most recent annual filing covers 2025 (period end 2025-12-31).
This page is refreshed whenever new regulator-filed data for INFARMED becomes available, consolidated into a single audit-grade view.
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €6,983 | €4,301 | €387,332 | €276,783 | - |
| 202431 Dec 2024 | €29,559 | €25,647 | €393,892 | €285,834 | - |
INFARMED was founded in 1989 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Besloten Vennootschap.
INFARMED is registered under NACE 86.10. That places the business within the Belgian cluster for this activity.
According to the company registry, INFARMED is based in Alken, BE.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-12-31), publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for INFARMED may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Indicative public valuation range based on financial year 2025. This historical record does not yet contain an immutable calculation snapshot, so no sector range is reconstructed after the fact. Not a transaction value, asking price or fairness opinion.
Public profiles for peers in the same industry and country. Click through to compare filings and indicative valuations.
